Publicaciones en las que colabora con MARIA CARMEN TERENCIO SILVESTRE (44)

2024

  1. Osteostatin Mitigates Gouty Arthritis through the Inhibition of Caspase-1 Activation and Upregulation of Nrf2 Expression

    International Journal of Molecular Sciences, Vol. 25, Núm. 5

2022

  1. Osteostatin Inhibits M-CSF+RANKL-Induced Human Osteoclast Differentiation by Modulating NFATc1

    International journal of molecular sciences, Vol. 23, Núm. 15

2019

  1. Osteostatin inhibits collagen-induced arthritis by regulation of immune activation, pro-inflammatory cytokines, and osteoclastogenesis

    International Journal of Molecular Sciences, Vol. 20, Núm. 16

2017

  1. Ex Vivo Tracking of Endogenous CO with a Ruthenium(II) Complex

    Journal of the American Chemical Society, Vol. 139, Núm. 51, pp. 18484-18487

2016

  1. Chondroprotective effects of the combination chondroitin sulfate-glucosamine in a model of osteoarthritis induced by anterior cruciate ligament transection in ovariectomised rats

    Biomedicine and Pharmacotherapy, Vol. 79, pp. 120-128

2015

  1. A Boron Dipyrromethene (BODIPY)-Based CuII-Bipyridine Complex for Highly Selective NO Detection

    Chemistry - A European Journal, Vol. 21, Núm. 44, pp. 15486-15490

  2. Effects of BIS076 in a model of osteoarthritis induced by anterior cruciate ligament transection in ovariectomised rats

    BMC Musculoskeletal Disorders, Vol. 16, Núm. 1

2014

  1. Influence of age on osteoarthritis progression after anterior cruciate ligament transection in rats

    Experimental Gerontology, Vol. 55, pp. 44-48

2013

  1. CO-releasing binuclear rhodium complexes as inhibitors of nitric oxide generation in stimulated macrophages

    Inorganic Chemistry, Vol. 52, Núm. 24, pp. 13806-13808

2012

  1. Analysis of early biochemical markers and regulation by tin protoporphyrin IX in a model of spontaneous osteoarthritis

    Experimental Gerontology, Vol. 47, Núm. 5, pp. 406-409

2008

  1. Treatment with a CO-releasing molecule (CORM-3) reduces joint inflammation and erosion in murine collagen-induced arthritis

    Annals of the Rheumatic Diseases, Vol. 67, Núm. 9, pp. 1211-1217

2007

  1. Evaluation of the anti-inflammatory and analgesic activity of Me-UCH9, a dual cyclooxygenase-2/5-lipoxygenase inhibitor

    Life Sciences, Vol. 80, Núm. 23, pp. 2108-2117

2006

  1. Heme oxygenase-1 inhibits apoptosis in Caco-2 cells via activation of Akt pathway

    International Journal of Biochemistry and Cell Biology, Vol. 38, Núm. 9, pp. 1510-1517

  2. Phenylsulphonyl urenyl chalcone derivatives as dual inhibitors of cyclo-oxygenase-2 and 5-lipoxygenase

    Life Sciences, Vol. 78, Núm. 25, pp. 2911-2918

2005

  1. Búsqueda y evaluación de nuevos agentes naturales con actividad antiinflamatoria y antiartrítica

    Revista de fitoterapia, Vol. 5, Núm. 1, pp. 82

  2. Influence of heme oxygenase 1 modulation on the progression of murine collagen-induced arthritis

    Arthritis and Rheumatism, Vol. 52, Núm. 10, pp. 3230-3238

2004

  1. Role of nuclear factor-κB and heme oxygenase-1 in the mechanism of action of an anti-inflammatory chalcone derivative in RAW 264.7 cells

    British Journal of Pharmacology, Vol. 142, Núm. 7, pp. 1191-1199

2003

  1. 1-(2,3,4-Trimethoxyphenyl)-3-(3-(2-chloroquinolinyl))-2-propen-1-one, a chalcone derivative with analgesic, anti-inflammatory and immunomodulatory properties

    Inflammation Research, Vol. 52, Núm. 6, pp. 246-257

  2. A new chloroquinolinyl chalcone derivatives as inhibitor of inflammatory and immune response in mice and rats

    Journal of Pharmacy and Pharmacology, Vol. 55, Núm. 9, pp. 1313-1321

  3. Cacospongionolide B suppresses the expression of inflammatory enzymes and tumour necrosis factor-α by inhibiting nuclear factor-κB activation

    British Journal of Pharmacology, Vol. 138, Núm. 8, pp. 1571-1579